Folate assays by use of radiolabeled folate provide obvious practical advantages over the standard microbiological assay, but remain incompletely tested. We therefore compared results for 415 sera with a kit involving 3H-labeled folate and the Lactobacillus case! microbiological method. We examined the patients' data when there were discrepancies between the two methods. Although the correlation overall was satisfactory, results were discrepant in 25% of cases. In 74% of the latter, the radioassay result appeared to be the correct one, primarily because Proper testing of radioassaymethods requires, among other things, careful comparison of results with those by the older method (Lactobacillus casei assay) and correlation with clinical and hematological data. Most published reports have provided comparison with microbiological assay. However, the number and selection of samples have not always been optimal, and in many instances (3-10) the correlation demonstrated between the assays has been inexact. Furthermore, even in the presence of an acceptable correlation coefficient, direct examination of the paired data often revealed a striking number of discrepancies (5, 11-14) which could not be attributed solely to the presence of antibiotics in the sera. Sometimes the authors thereupon only claimed that their radioassay was capable of differentiating between low and normal concentrations. Results were seldom examined for a wide variety of patients and clinical and hematological evaluation was rarely done in those cases where the two methodologies gave dissimilar results, aside from identifying instances where antibiotic use was responsible. Therefore, we present our results, where patients' data were retrospectively evaluated in an attempt to identify sources of discrepancies.
In fact, many of thesekitshave notbeen adequatelytested, oftendo not perform up tomanufacturers' claims (3, 4) , and furthermore are often modified by individual clinical laboratories without re-evaluation (1).
Proper testing of radioassaymethods requires, among other things, careful comparison of results with those by the older method (Lactobacillus casei assay) and correlation with clinical and hematological data. Most published reports have provided comparison with microbiological assay. However, the number and selection of samples have not always been optimal, and in many instances (3-10) the correlation demonstrated between the assays has been inexact. Furthermore, even in the presence of an acceptable correlation coefficient, direct examination of the paired data often revealed a striking number of discrepancies (5, (11) (12) (13) (14) which could not be attributed solely to the presence of antibiotics in the sera. Sometimes the authors thereupon only claimed that their radioassay was capable of differentiating between low and normal concentrations. Results were seldom examined for a wide variety of patients and clinical and hematological evaluation was rarely done in those cases where the two methodologies gave dissimilar results, aside from identifying instances where antibiotic use was responsible. Therefore, we present our results, where patients' data were retrospectively evaluated in an attempt to identify sources of discrepancies.
The radioassay kit selected for the main part of our study was one that we and others (3) have found to be among the most reliable of the many now commercially available.
Methods and Materials
Without conscious bias, we selected 415 serum samples submitted to our laboratory for folic acid determinations for use in the comparison. The blood samples had been centrifuged within 5 to 10 mm of receipt; however, the interval from blood drawing to receipt varied. Sera were stored at -20 #{176}C until assayed; repeated thawing and freezing was avoided.
Because the sera were kept frozen and were also to be assayed for vitamin B12, ascorbate was not added. Others have shown that serum stability is acceptable without added ascorbate (13, 15) , although the point remains controversial (7). We routinely use the L. casei microbiological assay (15) . Results were compared to those obtained with a [3H]pteroylglutamic acid (3H-PGA) kit (Diagnostic Products Corp., Los Angeles, Calif. 90064), the radioassay being done exactly as specified by the manufacturer, except that buffer pH was adjusted to 9.3 instead of 9.2, as recommended (16, 17) for better equivalence ofbinding of PGA and 5-methyltetrahydrofolic acidby milk binders; in the kit, fl-lactoglobulin--or, more precisely, an or on finding hypersegmented neutrophil nuclei) was accompanied by normal serum vitamin B12 concentrations. We also accepted folate deficiency as probable if, in the absence of vitamin B12deficiency, macrocytic anemia was associated with at least one of the following: response to subsequent folate therapy; co-existing disorders commonly associated with folate deficiency, such as sprue, anticonvulsant use, or pregnancy; a striking history of poor dietary intake; or Not shown are 11 sera for which points on the graph are superimposed on existing points and 26 sera for which radioassay results exceeded 24 Mg/lIter. L. casei assay gave a value of 5.1 Mg/liter for one of the latter, a serum which was contaminated by antibiotics (folate value was 37.2 Mg/liter by radloassay); two others also showed discrepancies, albeit lesser ones (13.6 and 17. an otherwise unexplained increased activity of serum lactate dehydrogenase (EC 1.1.1.27). On the other hand, a low folate concentration was deemed incorrect and the higher value was accepted if the patient was taking folic acidsupplements,
We also assayed selected serum samples with some other radioassay kits (Table 1) , following the manufacturers' instructions in each instance and using their normal ranges.
In one set of assays for each of two kits, serum-supernate control tubes were incorporated for each serum assayed. Such tubes were identical to the usual serum tubes except that an equivalent volume of buffer was substituted for the folate binder. The radioactivity in these tubes was subtracted from that of the serum tubes. We compared the resulting folate values to those obtained without subtracting the supernate control.
Results

Comparison of 3H-PGA Assay with L. case! Assay
Several sera were assayed repeatedly during several months, to determine inter-assay variation. The 3H-PGA assay gave a mean of6.7 ± 1.7 (1 SD) zg/liter with a standard error of 0.33 for one normal serum in 26 observations, and a mean of 5.3 ± 0.5 big/liter with a standard errorof 0.16fora second innine observations.
Respective L. casei assay means for the same two sera were 8.6 ± 1.9 and 4.3 ± 0.3 ag/liter, with standard errors of0.24and 0.02 in 60 and 108 observations, respectively. Omission of ascorbate can also be seen to have had no effect on folate stability. Similar evaluation ofeightlow-folate sera was done with L. casei assay. Mean values ranged from 1.2± 0.1 to 2.8 ± 0.4 pig/liter in eight to 15 observations; standard errors ranged from 0.03 to 0.11.
Comparison of results for the 415 sera by the two methods gave a correlation coefficient of 0.87, but Figure 1 demonstrates the wide scatter in many cases. Analysis by chart review was possible in 85 cases where there were discrepant results, as defined in the previous section ( Table 2 ). The following specific points can be made: (a) isotopic contamination of serum, usually from gallium or technetium given the patient for scans (19) , falsely lowered radioassay results in four cases, in two of which the values thereupon fell into a different diagnostic category; (b) 25 of the 45 falsely low L. casei assay results could be attributed to antibiotics given the patient, and inonly11ofthose 25 sera did we suspect this problem during the assay by noting decreasing microbial growth with increasing volume of serum; and (c) 14 patients with megaloblastic anemia not caused by vitamin B12 deficiency, and thus apparently attributable to folate deficiency, gave falsely high results for 3H-PGA assay (3.2-11.2 ,g/liter, as compared with <1.0-4.1 tg/liter by L. casei assay). Interestingly, 13 of those 14 patients had alcoholic liver disease, and the other had chronic renal failure. The 3H-PGA assayrequires scintillation counting, and so we at first suspected quenching by hyperbilirubinemia of causingthe falsely high radioassay results above. However, correcting for quench did not alter the values significantly.
Evaluation of 1251-labeled PGA and 75Se-labeled Folate Kits
We selected 34 sera for assay with one or another of the 1251-labeledPGA kits and 33 for assay with the 75Se-labeled folate kit. Because the numbers involved were small and many serawere selected specifically becauseof discrepancy between results by 3H-PGA and L. casei assay, only limited conclusions are possible. Nevertheless, in sera with discrepant results all the radioassay methods tended to agree with each other more often than with L. casei assay (Table 3) . This was particularly true in sera from patients with liver disease, although in two such sera '251-PGA assay results agreed with L. casei rather than with 3H-PGA assay results. 125I-PGA and 3H-PGA assay results correlated well (r = 0.91 for all 34 sera). However, the New England Nuclear kit, and to a much lesser extent the other two 1251-PGA kits, produced consistently lower results than did the 3H-PGA kit. The [75Se]folate assay results correlated slightly less well with 3H-PGA assay results (r = 0.82) than did the 1251-PGA kits.
Evaluation of Serum-Supernate Controls
Residual binding for folate by serum was negligible with the 3H-PGA kit. Radioactivity in the serum-supernate control tube barelyexceeded background activity and did not vary among the 18 specimens tested, which included sera from patients with liver disease, renal failure, or leukemia. In contrast, supernatant counts with the [75Se]folate kit were sizeable in the 13 sera tested. Equally importantly, these counts varied among the different sera, ranging from 10 to 65% of the E75Se] folate counts bound by the folate binder for that particular serum (mean of 16% ± 24). Table 4 illustrates their effect on results for serum folate.
Discussion
Comparisons of folatemethodologiesin which clinical correlation has been attempted have heretofore been rare. Although ours was not a prospective study and in several cases presence or absence of folate deficiency could not be established definitively, several conclusions are possible. First, despite a respectable correlation coefficient overall, fully 25% of our sera fell in different diagnostic categories when tested by microbiological assay and by Diagnostic Products' 3H-PGA radioassay. The wide scatter in Figure 1 is striking.
Second, in those 61 cases where a reasonable conclusion could be drawn about which of the two assay results was correct, the radioisotopic assay was correct 74% of the time. This was so chiefly because of the many microbiological assay results suppressed by the antibiotics being given the patient. If we omit antibiotic-containing sera from analysis, then the distribution of incorrect results is similar between the two methods. Apparently, therefore, the chief advantage in reliability for the radioassay is that it is better if one often deals with sera from patients for receiving antibiotics. The two chief identifiable disadvantages of the 3H-PGA radioassay are that it gives falsely high results in patients with liver disease and, as described previously (19) , falsely low ones when the patient has received injections of isotopes. The explanation for the apparent radioassay artifact in some patients with liver disease is not apparent. Quenching in the 3H-PGA assay did not appear to be responsible. We found the artifact to be the opposite of that described by Kamen and Caston (8).
Third, in a limited
series, folate radioassays using gamma-emitting isotopes gave results generally corresponding with those of the 3H-PGA radioassay.
However, several instances of variance were noted, particularly with the New England Nuclearkit, as noted by others (14 In summary, our findings indicate that none ofthe assay methodologies is consistently reliable. Although significant discrepancies in resultsbetween microbiological and radioisotopic folate assays are frequent, the latter, at least in the form of Diagnostic Products' 3H-PGA kit, may be the most practical of those we have tested. Given the frequency of antibiotic contamination that we encountered, the latter method may actually be preferable to the microbiological assay because results with it are more often correct. However, sera from patients with liver disease often gave falsely high results by radioassay, and little is known about the other causes of discrepant results. Studies to elucidate the cause of the above artifact of the radioassay would be important.
Obviously, too, all new methods must be subjected to prospective analyses with careful clinical correlation before they can be adopted for routine use.
We thank the manufacturers of the five radioassay kits listed in Table 1 
